Louisiana biologics regulations.

Who may administer PRP, exosomes and stem cells in Louisiana, and which agencies to check.

A physician at a desk reading regulatory documents

Who may administer biologics in Louisiana?

In Louisiana, only licensed medical professionals (MDs/DOs) can administer stem cell therapies. Meeting these requirements ensures that practitioners are adequately trained, promoting safety and legal compliance.

Official sources

Louisiana compliance guide.

FDA Compliance

Biologic therapies are regulated under the FDA’s Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/P) guidelines. To ensure compliance, refer to the FDA’s Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/P). This regulation outlines key criteria, such as minimal manipulation and homologous use, for classifying stem cell and other biologic products.

Additional compliance requirements may include Current Good Manufacturing Practice (CGMP) guidelines and adherence to federal laboratory standards for production and processing of biologics. Consult the FDA’s Vaccines, Blood, and Biologics section for a full overview of federal compliance requirements.

Louisiana State Regulations

Louisiana's state regulations on biologics are governed by the Louisiana Department of Health. Clinics must comply with both federal and state regulations for safe administration of stem cell treatments. For specific guidelines and updates, visit the Louisiana Department of Health website.

Louisiana providers should also review local ordinances or licensing requirements that may apply. Compliance is achievable by understanding these guidelines and staying informed on updates from the state health department.

Provider Qualifications

In Louisiana, only licensed medical professionals (MDs/DOs) can administer stem cell therapies. For investigational HCT/Ps IRB oversight is required. Review the specific licensure requirements through the Louisiana State Board of Medical Examiners.

Meeting these requirements ensures that practitioners are adequately trained, promoting safety and legal compliance. Clinics are encouraged to support staff development and licensure maintenance.

Patient Informed Consent

Informed consent is crucial for biologic therapies, especially as some treatments remain investigational. Louisiana clinics must clearly communicate the risks, potential benefits, and experimental nature of certain therapies. Consent forms should outline:

  • The purpose of the treatment, including that it may be investigational.
  • Potential benefits, limitations, and risks associated with the therapy.
  • Alternatives to the treatment, where applicable.Comprehensive documentation helps protect both patients and providers, emphasizing transparency and ethical practice.

Additional Compliance Guidelines

Pre-Treatment and Post-Treatment Protocols

Clinics should establish Standard Operating Procedures (SOPs) for patient screening, pre-treatment counseling, and post-treatment care. These protocols support patient safety and regulatory compliance.

Medical Liability Insurance

Medical liability insurance is highly recommended for providers of biologic therapies. This coverage helps manage risks associated with patient care and compliance.

Marketing Compliance

Louisiana clinics must ensure that all marketing materials are compliant with FDA and FTC guidelines. Avoid making unsubstantiated claims and clearly disclose the investigational nature of experimental therapies. For further information, see the FDA’s Advertising and Promotion guidelines.

This guide is a general summary to help clinics understand compliance requirements for biologics in Louisiana. It is not legal advice. Regulations change; consult legal counsel and the agencies above before acting on it.

Louisiana: common questions.

Who can administer stem cells, PRP and exosomes in Louisiana?
In Louisiana, only licensed medical professionals (MDs/DOs) can administer stem cell therapies. Meeting these requirements ensures that practitioners are adequately trained, promoting safety and legal compliance. This is a general summary, not legal advice. Confirm with the state board.
Are stem cell and exosome therapies FDA-approved in Louisiana?
FDA rules are federal, so they apply in Louisiana as everywhere else. Exosome and stem cell therapies are not FDA-approved for therapeutic use, and PRP applications are considered off-label.
Do I need an IRB-approved study to offer biologics in Louisiana?
Investigational treatment belongs inside a reviewed study with proper informed consent. IRB review is not FDA authorisation: culture-expanded and other more-than-minimally-manipulated cell products generally need an IND before use in people.
How do I start offering biologics in Louisiana?
Start with the live webinar, then a discovery call and live training. After that we verify your Louisiana licence, protocol, product sourcing, consent process and advertising before you are listed for patient inquiries.

Practising in Louisiana? Start with the webinar.

Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.